Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global DNA Sequencing Market size was valued at USD 16.75 Billion in 2024 and is poised to grow from USD 19.61 Billion in 2025 to USD 69.33 Billion by 2033, growing at a CAGR of 17.1% in the forecast period (2026–2033).

    The global DNA sequencing industry is highly competitive with a combination of established leaders and new innovators continuing to drive new technology and applications. Illumina continues to maintain its dominance with a well-established and diverse range of sequencing platforms and consumables. Thermo Fisher Scientific uses Ion Torrent technology and its well-established life sciences ecosystem. 'Illumina, Inc.', 'Thermo Fisher Scientific, Inc.', 'Pacific Biosciences of California, Inc.', 'Oxford Nanopore Technologies plc', 'BGI Genomics Co., Ltd.', 'QIAGEN N.V.', 'Agilent Technologies, Inc.', 'F. Hoffmann-La Roche Ltd.', 'Macrogen, Inc.', 'Genomic Health, Inc.', 'PerkinElmer, Inc.', 'Eurofins Scientific SE'

    Current improvements in next-generation sequencing technologies (long read sequencing, nanopore) are facilitating market uptake. The added advantage of these technologies is the reduced cost of sequencing, the heightened accuracy of reads and the analysis timeframe (both short- and longer-term). These emerging technologies are lowering the costs of sequencing, improving read accuracy and providing more rapid and timely analysis. The ongoing integration of AI-powered bioinformatics tools becomes another level of enhancement to speed and accuracy of interpretation to make sequencing accessible within clinical laboratories, research institutes, and now increasingly for point-of-care contexts. This is particularly advantageous to fields like precision oncology, diagnostics for rare disease, and infectious disease

    Shift Toward Long-Read and Single-Cell Sequencing: Long-read sequencing techniques, like HiFi sequencing from Pacific Biosciences, and Oxford Nanopore with its long-read sequencing devices, are becoming popular for their ability to capture complex genomic regions, structural variants, and repeat sequences more accurately. In contrast, single-cell sequencing's unparalleled resolution for detecting gene heterogeneity in various fields including neuroscience, cancer research, and immunology is rapidly becoming a common choice.

    How is the DNA Sequencing Market Performing in North America?

    Feedback From Our Clients

    Global DNA Sequencing Market

    Report ID: SQMIG35H2380

    $5,300
    BUY NOW